Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Other financing activities (2020 - 2021)

Historic Other financing activities for Barinthus Biotherapeutics (BRNS) over the last 2 years, with Q3 2021 value amounting to $1.4 million.

  • Barinthus Biotherapeutics' Other financing activities changed N/A to $1.4 million in Q3 2021 from the same period last year, while for Dec 2021 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2021, which is 369824.56% up from last year.
  • As of Q3 2021, Barinthus Biotherapeutics' Other financing activities stood at $1.4 million.
  • Over the past 5 years, Barinthus Biotherapeutics' Other financing activities peaked at $1.4 million during Q3 2021, and registered a low of $22000.0 during Q1 2021.